Oliver Politz
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Biotechnology top 2%
- Enzyme Production and Characterization
Papers in
-
- Enzyme Production and Characterization 7
-
- Immune Response and Inflammation 4
- Immune cells in cancer 3
- Co-authors
- Sergij Goerdt (9 shared papers)Vitam Kodelja (5 shared papers)Pierre Guillot (5 shared papers)Kai Schledzewski (5 shared papers)C. Müller (2 shared papers)A. N. Gratchev (4 shared papers)Rainer Borriss (8 shared papers)Nahid Hakiy (3 shared papers)
- Journals
- European Journal of Biochemistry (4 papers)Molecular Cancer Therapeutics (2 papers)International Journal of Cancer (2 papers)FEBS Journal (2 papers)Biochemical Journal (2 papers)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
Oliver Politz
37 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 106
- Immunology 755
- Biotechnology 251
- Immunology and Allergy 123
- Oncology 422
- Molecular Biology 988
Countries citing papers authored by Oliver Politz
This map shows the geographic impact of Oliver Politz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Politz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Politz more than expected).
Fields of papers citing papers by Oliver Politz
This network shows the impact of papers produced by Oliver Politz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Politz. The network helps show where Oliver Politz may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Politz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 295 | |
| 2 | 2002 | 258 | |
| 3 | 2001 | 242 | |
| 4 | Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. | 1998 | 230 |
| 5 | 1998 | 210 | |
| 6 | 2002 | 194 | |
| 7 | 2007 | 134 | |
| 8 | 1995 | 99 | |
| 9 | 2004 | 94 | |
| 10 | 2019 | 76 | |
| 11 | 2016 | 73 | |
| 12 | 1998 | 69 | |
| 13 | 2000 | 68 | |
| 14 | 2004 | 56 | |
| 15 | 2016 | 53 | |
| 16 | 2001 | 38 | |
| 17 | 2023 | 38 | |
| 18 | 1993 | 32 | |
| 19 | 2000 | 28 | |
| 20 | 2020 | 25 |
About Oliver Politz
Oliver Politz is a scholar working on Biotechnology, Immunology, Oncology, Cancer Research and Molecular Biology, having authored 37 papers that have together received 2.5k indexed citations. Recurring topics across this work include Enzyme Production and Characterization (7 papers), Biofuel production and bioconversion (7 papers), Immune Response and Inflammation (4 papers), Microbial Metabolites in Food Biotechnology (4 papers), Chemokine receptors and signaling (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Prostate Cancer Treatment and Research (4 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Immunology (755 citations), Biotechnology (251 citations), Immunology and Allergy (123 citations), Oncology (422 citations) and Molecular Biology (988 citations). Oliver Politz has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Sergij Goerdt, Vitam Kodelja, Pierre Guillot, Kai Schledzewski, C. Müller, A. N. Gratchev, Rainer Borriss, Nahid Hakiy, Bernard Haendler and Constantin E. Orfanos. Their work appears in journals such as European Journal of Biochemistry, Molecular Cancer Therapeutics, International Journal of Cancer, FEBS Journal and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.